SCHEMBL25923360

SCHEMBL25923360

BC1CC(n2cc3cc(Br)cc(C(F)(F)F)c3n2)C1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 6/20 0.38
KDM1A O60341 2/20 0.31
TLR7 Q9NYK1 1/20 0.31
EPRS1 P07814 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25317472 0.82 TLR8 (0.42) TLR8KDM1ATLR7EPRS1
SCHEMBL25923351 0.79 TLR8 (0.38) TLR8EPRS1
SCHEMBL25314887 0.79 TLR8 (0.38) TLR8EPRS1
SCHEMBL22172245 0.71 HTT (0.37) TLR8EPRS1
SCHEMBL25923371 0.71 TLR8 (0.40) TLR8TLR7
SCHEMBL25923353 0.64 AR (0.40) TLR8
SCHEMBL25316918 0.64 AR (0.40) TLR8
SCHEMBL25938341 0.64 TLR8 (0.41) TLR8TLR7
SCHEMBL25197710 0.62 TLR8 (0.34) TLR8TLR7
SCHEMBL25114046 0.61 PDE4D (0.45) TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed